Skip to Content

Ioflupane I 123 Pregnancy and Breastfeeding Warnings

Ioflupane I 123 is also known as: DaTscan

Ioflupane I 123 Pregnancy Warnings

Use is not recommended unless clearly needed. US FDA pregnancy category: C Comments: Assess for the presence of pregnancy prior to administering this drug to women of childbearing potential.

Animal reproductive and developmental toxicity studies have not been conducted. Like all radiopharmaceuticals, this drug has a potential to cause fetal harm. The likelihood of fetal harm depends on the stage of fetal development, and the magnitude of the radionuclide dose. Administration of ioflupane I-123 at a dose of 185 MBq (5 mCi) results in an absorbed radiation dose to the uterus of 0.3 rad (3.0 mGy). Radiation doses greater than 15 rad (150 mGy) have been associated with congenital anomalies. Radioactive iodine products cross the placenta and can permanently impair fetal thyroid function. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Ioflupane I 123 Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: -The effects in the nursing infant are unknown. -Consider interrupting nursing and pumping and discarding breast milk for 6 days after administration of this drug in order to minimize risks to a nursing infant.

See references

References for pregnancy information

  1. "Product Information. DaTscan (ioflupane I-123)." GE Healthcare, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. DaTscan (ioflupane I-123)." GE Healthcare, Princeton, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.